Considering that PRDM1 is one of the key regulators of normal plasma cell differentiation, we hypothesized that the aberrant regulation of one of the members of the PRDM family could have a significant impact on MM pathogenesis. This evidence concerns the gene PRDM1 and Miyoshi myopathy.